aminoacridine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
acridine derivatives 160 90-45-9

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • aminacrine hydrochloride
  • aminoacridine
  • 9-Acridinamine monohydrochloride
  • 9-Aminoacridine monohydrochloride
  • NSC-7571
  • aminacrine
  • 9-Aminoacridine
  • aminacrin
  • izoacridina
  • monacrin
  • aminacrine HCl
A highly fluorescent anti-infective dye used clinically as a topical antiseptic and experimentally as a mutagen, due to its interaction with DNA. It is also used as an intracellular pH indicator.
  • Molecular weight: 194.24
  • Formula: C13H10N2
  • CLOGP: 3.09
  • LIPINSKI: 0
  • HAC: 2
  • HDO: 1
  • TPSA: 38.91
  • ALOGS: -3.41
  • ROTB: 0

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 1.542 Moderate 0.67
caco2-efflux Caco-2 efflux ratio (BA/AB) 0.461 Moderate 0.67
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 34.914 10^-6 cm/s Moderate 0.67
dh-clint Dog hepatocyte intrinsic clearance 59.979 uL/min/10^6 cells Moderate 0.67
dppb Dog plasma protein binding (% unbound) 20.940 % Moderate 0.67
fcs-ppb Fetal calf serum protein binding (% unbound) 55.730 % Moderate 0.67
herg hERG pIC50 5.670 pIC50 Moderate 0.67
hh-clint Human hepatocyte intrinsic clearance 22.284 uL/min/10^6 cells Moderate 0.67
hlm-clint Human liver microsomal intrinsic clearance 77.625 uL/min/mg protein Moderate 0.67
hppb Human plasma protein binding (% unbound) 22.830 % Moderate 0.67
kinase-safety-class ACVR1B,ACVR2A,ACVR2B,AKT2,AKT3,ALK,AURKA,AURKB,AURKC,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK1,CDK4,CDK5,CDK9,CHEK1,CLK4,CSF1R,DDR1,DYRK1B,EGFR,EIF2AK3,EPHA2,EPHB4,ERBB2,FLT3,GRK1,GRK2,GRK3,GSK3B,IKBKB,IRAK1,ITK,JAK1,JAK2,JAK3,KIT,MAP2K6,MAP3K1,MAP3K10,MAP3K11,MAP3K14,MAP3K21,MAP3K7,MAP4K1,MAP4K3,MAP4K5,MAPK1,MAPK10,MAPK12,MAPK7,MAPK8,MAPK9,MAPKAPK2,MARK4,MELK,MET,MTOR,NTRK2,PAK4,PDK2,PDK4,PDPK1,PIK3CB,PIK3CD,PIM1,PIM2,PLK1,PRKCD,PRKDC,SGK1,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TNIK,TTK,TYRO3,ULK1,ULK2,ZAP70 86
kinase-selectivity-class ACVR2A,ACVR2B,AURKA,AXL,BRAF,CAMK2D,CDK9,DDR1,DYRK1B,GRK2,MAP2K3,MAP2K6,MAP3K10,MAP3K21,MAPK7,MARK4,MET,PDK4,PIK3CD,SIK2,SIK3,STK33,TTK,ULK1 24
mdck-mdr1-bcrp-efflux MDCK-MDR1-BCRP efflux ratio 0.615 Moderate 0.67
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 2.173 Moderate 0.67
mh-clint Mouse hepatocyte intrinsic clearance 88.920 Moderate 0.67
mppb Mouse plasma protein binding (% unbound) 23.280 Moderate 0.67
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 1.660 Moderate 0.67
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pld-class Phospholipidosis risk class (1 = positive, 0 = negative) 1 Moderate 0.67
pppb Pig plasma protein binding (% unbound) 31.570 % Moderate 0.67
rat-kpuu-brain Rat brain Kpuu 0.731 % Moderate 0.67
rh-clint Rat hepatocyte intrinsic clearance 58.614 uL/min/10^6 cells Moderate 0.67
rh-fuinc Rat hepatocyte fraction unbound in incubation 71.240 % Moderate 0.67
rppb Rat plasma protein binding (% unbound) 28.010 % Moderate 0.67
solubility-dd Solubility at pH 7.4 in DMSO 765.597 uM Moderate 0.67

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC D08AA02 DERMATOLOGICALS
ANTISEPTICS AND DISINFECTANTS
ANTISEPTICS AND DISINFECTANTS
Acridine derivatives
MeSH PA D000890 Anti-Infective Agents
MeSH PA D000891 Anti-Infective Agents, Local
MeSH PA D004396 Coloring Agents
MeSH PA D005456 Fluorescent Dyes
MeSH PA D007202 Indicators and Reagents
MeSH PA D009153 Mutagens
MeSH PA D049408 Luminescent Agents
CHEBI has role CHEBI:25435 mutagen
CHEBI has role CHEBI:35441 antiinfective agent
CHEBI has role CHEBI:48218 antiseptic drug
CHEBI has role CHEBI:50407 acid-base indicator
CHEBI has role CHEBI:51121 fluorescent dye
CHEBI has role CHEBI:64345 MALDI matrix material

Related Drugs by ATC class:

D08AA Acridine derivatives 2 drugs
ethacridineeuflavine

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Kidney disease contraindication 90708001 DOID:557
Anemia due to enzyme deficiency contraindication 111577008
Deficiency of glucose-6-phosphate dehydrogenase contraindication 124134002 DOID:2862
Disease of blood AND/OR blood-forming organ contraindication 191124002 DOID:74
Disease of liver contraindication 235856003 DOID:409
Porphyria contraindication 418470004




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 9.54 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])		Mechanism
action		Bioact sourceMoA source
Ribosyldihydronicotinamide dehydrogenase [quinone] Enzyme IC50 6.36 CHEMBL
Amine oxidase [flavin-containing] A Enzyme IC50 4.58 CHEMBL
Trypanothione reductase Enzyme Ki 4.42 CHEMBL

External reference:

IDSource
4018614 VUID
N0000179393 NUI
D02905 KEGG_DRUG
134-50-9 SECONDARY_CAS_RN
645 RXNORM
C0002503 UMLSCUI
CHEBI:51803 CHEBI
AA PDB_CHEM_ID
CHEMBL43184 ChEMBL_ID
7019 PUBCHEM_CID
DB11561 DRUGBANK_ID
CHEMBL1330022 ChEMBL_ID
NOCODE MMSL
D000585 MESH_DESCRIPTOR_UI
1476 INN_ID
4018614 VANDF
4019604 VANDF
OR5RM3Q5QL UNII
002960 NDDF
004875 NDDF
391756001 SNOMEDCT_US
6602005 SNOMEDCT_US
714291009 SNOMEDCT_US

Pharmaceutical products:

None